Mitchell A. Jackson

Mitchell A. Jackson, M.D. is the founder and CEO of Jacksoneye in Illinois and has practiced as a comprehensive ophthalmologist for 28 years. He graduated from Pomona College, completed his medical training at FUHS/The Chicago Medical School, and completed his Ophthalmology residency at the University of Chicago Hospitals. Dr. Jackson has been involved in over 40 pharmaceutical and surgical device clinical studies, including several presbyopia studies. Dr. Jackson serves on 7 editorial advisory boards, including Presbyopia Physician. Dr. Jackson serves as a member of the medical advisory board of several companies, and a speaker for some of the largest ophthalmic companies. Dr. Jackson has been voted Best Cataract Surgeon in America 2021 as well as a Top 50 global Key Opinion Leaders (KOL). He is a clinical investigator in Ocuphire's MIRA-3 Phase 3 clinical trial.